CCEP's Q2 Arrives With Full-Year Targets Already Under Scrutiny

Coca-Cola Europacific Partners Plc (CCEP) reports Q1 2026 earnings on June 9, 2026, with investors focused on whether the beverage bottler can sustain the momentum from its strong 2025 performance. The company faces a critical test as it navigates volume growth dynamics and pricing power across its European and Asia-Pacific markets. With analyst sentiment firmly bullish and the stock trading near key technical levels, this report will reveal whether CCEP's revenue-per-case strategy continues to drive earnings growth.

Part 1: Earnings Preview

Coca-Cola Europacific Partners is one of the world's largest independent Coca-Cola bottlers, serving approximately 600 million consumers across 31 countries in Europe, Asia-Pacific, and Indonesia. The company generates revenue through the sale of sparkling soft drinks, water, sports drinks, and other non-alcoholic beverages across its diverse geographic footprint.

CCEP reports Q1 2026 results on June 9, 2026. Wall Street analysts have not published consensus EPS or revenue estimates for the quarter, reflecting limited coverage for this reporting period. The company most recently reported Q4 2025 earnings of $1.35 per share, which represented a substantial beat versus the $0.91 consensus estimate. Year-over-year comparisons are unavailable due to lack of data for Q1 2025.

Three key themes define this earnings story:

Revenue Per Unit Case Growth: CCEP's Q1 2026 trading update showed revenue per unit case increasing 9.4% on an FX-neutral basis, driven by 8.5% comparable growth. This metric has become the primary driver of earnings expansion as the company balances volume growth with pricing discipline. Investors will scrutinize whether this momentum continued through the full quarter and if the company can maintain pricing power without sacrificing volume.

Geographic Performance Divergence: The company's Europe segment delivered 9.8% FX-neutral revenue growth in Q1, while Asia-Pacific showed 8.6% growth. The divergence between regions—particularly Europe's stronger performance—will be critical as investors assess the sustainability of growth across CCEP's footprint and whether emerging market headwinds are materializing.

Full-Year 2026 Guidance Trajectory: Management provided FY26 guidance in February 2026, and this report will offer the first checkpoint on progress toward those targets. With full-year 2026 EPS estimates of $5.00 representing 7.53% growth, investors need confirmation that Q1 results support the annual outlook and that no material headwinds have emerged.

Analyst commentary ahead of the release has been constructive. UBS maintains a Buy rating on the stock, reflecting confidence in CCEP's execution and market position. The bullish stance from leading analysts suggests expectations for continued operational momentum, though the lack of published quarterly estimates indicates some uncertainty about near-term earnings power.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 2.94% (±$2.81) through June 18, 2026, with the stock anticipated to trade between $92.56 and $98.17. Without historical earnings move data available for comparison, investors should view this expected move as the market's current assessment of post-earnings volatility, though it cannot be contextualized against CCEP's typical earnings reactions.

Part 3: What Analysts Are Saying

Analyst sentiment on CCEP is decidedly bullish heading into earnings. The consensus rating stands at 4.14 out of 5.0, reflecting strong conviction in the stock's prospects. The analyst community shows 9 Strong Buy ratings, 0 Moderate Buys, 4 Holds, 0 Moderate Sells, and 1 Strong Sell among 14 analysts covering the stock.

The average price target of $107.45 implies 12.8% upside from the current price of $95.25, with a target range spanning from $81.00 to $118.00. This wide range reflects differing views on valuation, though the concentration of Strong Buy ratings indicates most analysts see meaningful appreciation potential.

Sentiment has remained unchanged over the past month, with the rating distribution holding steady at 4.14. This stability suggests analysts are maintaining their bullish stance rather than adjusting views ahead of the earnings release. The consistency in ratings indicates confidence in CCEP's business trajectory and suggests analysts believe current estimates are achievable. The lone Strong Sell rating represents a clear outlier in an otherwise optimistic consensus, likely reflecting concerns about valuation or market-specific risks that the broader analyst community does not share.

Part 4: Technical Picture

CCEP enters earnings with a Buy signal at 8% on the Barchart Technical Opinion, representing a dramatic shift from last week's Sell signal at 56%. This reversal indicates recent price strength has improved the technical picture, though the signal remains at minimum strength. One month ago, the indicator also showed a Buy signal at 8%, suggesting the stock has returned to a modestly constructive setup after a brief period of weakness.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal suggests near-term momentum faces headwinds and caution is warranted into the earnings event
• Medium-term (50% Buy): Moderate buy signal indicates the intermediate trend remains constructive despite short-term weakness
• Long-term (50% Buy): Moderate buy signal reflects a positive longer-term trend structure that supports the bullish case

Trend Characteristics: The signal shows minimum strength with a weakening direction, indicating the technical environment is fragile heading into earnings despite the recent improvement to a Buy signal.

The stock is currently trading at $95.25, positioned above its 5-day ($93.08), 10-day ($92.62), 20-day ($92.50), 50-day ($94.05), and 200-day ($92.85) moving averages, but below its 100-day moving average ($95.88). This configuration shows the stock has reclaimed most key support levels but faces resistance at the 100-day average.

The technical setup presents a mixed picture for earnings. While CCEP has recovered above most moving averages and sits near the psychologically important $95 level, the 100-day moving average at $95.88 represents immediate overhead resistance. The conflicting timeframe signals—with short-term weakness offset by medium and long-term strength—suggest the stock could experience heightened volatility around the earnings release. The weakening trend direction despite the Buy signal indicates technical momentum is not firmly established, making the stock vulnerable to a sharp move in either direction depending on results and guidance. Traders should note the stock's position just below the 100-day average creates a clear technical level to watch: a strong earnings beat could propel CCEP through this resistance, while disappointment could trigger a retreat toward the 50-day average at $94.05.